The complex interplay between diabetes mellitus and atrial fibrillation

Area of Science:

• Cardiology
• Endocrinology
• Public Health

Background:

• Diabetes mellitus (DM) is linked to increased risk of new-onset atrial fibrillation (AF).
• Shared risk factors, pathophysiological mechanisms, atrial remodeling, and autonomic dysfunction contribute to AF prevalence in DM patients.
• The coexistence of DM and AF leads to adverse outcomes, including reduced quality of life, thromboembolic events, heart failure, and mortality.

Purpose of the Study:

• To review current data on DM's role in AF development and prognosis.
• To examine the impact of anti-diabetic medications on AF prevention.
• To discuss anticoagulation strategies for patients with both DM and AF.

Main Methods:

• Comprehensive literature review of existing data.
• Analysis of observational studies and expert opinions.
• Synthesis of evidence regarding DM, AF, and treatment implications.

Main Results:

• DM is an independent risk factor for new-onset AF.
• Coexisting DM and AF significantly worsen patient prognosis.
• Current evidence is insufficient for routine AF screening in DM patients.
• Potential benefits of anti-diabetic medications for AF prevention require further investigation through randomized controlled trials.

Conclusions:

• DM independently increases the risk of developing AF and negatively impacts prognosis.
• Further research, particularly randomized controlled trials, is essential to evaluate anti-diabetic medications for AF prevention.
• Optimal management strategies for patients with both DM and AF, including anticoagulation, need continued exploration.